MCID: THY102
MIFTS: 53

Thyroid Cancer, Nonmedullary, 2 malady

Categories: Genetic diseases, Rare diseases, Cancer diseases, Endocrine diseases

Aliases & Classifications for Thyroid Cancer, Nonmedullary, 2

About this section

Aliases & Descriptions for Thyroid Cancer, Nonmedullary, 2:

Name: Thyroid Cancer, Nonmedullary, 2 49
Follicular Thyroid Carcinoma 10 45 12 65
Thyroid Carcinoma, Follicular 49 11 45
Thyroid Cancer, Follicular 45 65
Follicular Thyroid Cancer 47 24
Follicular Adenocarcinoma, Well Differentiated 10
Follicular Carcinoma of the Thyroid Gland 10
Thyroid Carcinoma, Follicular, Somatic 49
Thyroid Carcinoma, Follicular Somatic 22
 
Thyroid Cancer, Non-Medullary, 2 67
Thyroid Gland Adenocarcinoma 65
Thyroid Follicular Carcinoma 47
Adenocarcinoma, Follicular 36
Follicular Adenocarcinoma 10
Thyroid Adenocarcinoma 10
Follicular Carcinoma 10
Nmtc2 67
Ftc 45

Characteristics:

HPO:

61
thyroid cancer, nonmedullary, 2:
Inheritance: autosomal dominant inheritance


Classifications:



External Ids:

OMIM49 188470
Disease Ontology10 DOID:3962
NCIt42 C8054
MedGen34 C0206682
UMLS65 C0206682, C1704228, C2931367

Summaries for Thyroid Cancer, Nonmedullary, 2

About this section
OMIM:49 Nonmedullary thyroid cancer (NMTC) comprises thyroid cancers of follicular cell origin and accounts for more than 95%... (188470) more...

MalaCards based summary: Thyroid Cancer, Nonmedullary, 2, also known as follicular thyroid carcinoma, is related to thyroiditis and lung cancer, and has symptoms including follicular thyroid carcinomaand abnormality of metabolism/homeostasis. An important gene associated with Thyroid Cancer, Nonmedullary, 2 is SRGAP1 (SLIT-ROBO Rho GTPase Activating Protein 1), and among its related pathways are p38MAPK events and VEGF ligand-receptor interactions. Affiliated tissues include thyroid, lymph node and lung, and related mouse phenotypes are limbs/digits/tail and respiratory system.

Disease Ontology:10 A thyroid carcinoma that has material basis in follicular cells.

UniProtKB/Swiss-Prot:67 Thyroid cancer, non-medullary, 2: A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms.

Related Diseases for Thyroid Cancer, Nonmedullary, 2

About this section

Diseases in the Thyroid Cancer, Nonmedullary, 2 family:

Thyroid Cancer, Nonmedullary, 4 Thyroid Cancer, Nonmedullary, 5

Diseases related to Thyroid Cancer, Nonmedullary, 2 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 320)
idRelated DiseaseScoreTop Affiliating Genes
1thyroiditis30.9TG, TPO, TSHR
2lung cancer30.0EGF, HRAS, KDR, NKX2-1, NME1, NRAS
3familial papillary or follicular thyroid carcinoma12.5
4trabecular follicular adenocarcinoma12.5
5papillary follicular thyroid adenocarcinoma12.3
6thyroid carcinoma, hurthle cell11.7
7differentiated thyroid carcinoma11.5
8tetrasomy 12p10.7HRAS, NRAS
9melanocytic nevus syndrome, congenital, somatic10.6HRAS, NRAS
10sigmoid disease10.6HRAS, NRAS
11laryngeal mucoepidermoid carcinoma10.6CALCA, TG
12mucosal melanoma10.6HRAS, NRAS, PTEN
13diabetic encephalopathy10.6HRAS, NRAS
14autoimmune thyroiditis10.6TG, TPO
15skin angiosarcoma10.6CALCA, TG
16thyroid ectopia10.6TG, TPO
17pneumonic plague10.6CALCA, HRAS, NRAS
18congenital structural myopathy10.6HRAS, NRAS, PAX8
19cavernous hemangioma10.6HRAS, NRAS, RET
20anterior horn cell disease10.5HRAS, NKX2-1, NRAS
21iatrogenic or traumatic pituitary deficiency10.5PAX8, TG, TSHR
22neonatal meningitis10.5TG, TPO
23epidermal nevus, somatic10.5HRAS, NRAS
24mediastinum teratoma10.5NKX2-1, RET, TG
25rhabdomyosarcoma, embryonal, 210.5TG, TPO
26tracheal lymphoma10.5HRAS, NRAS, PTEN
27dubin-johnson syndrome10.5HRAS, NRAS, PTEN
28schimmelpenning-feuerstein-mims syndrome, somatic mosaic10.5HRAS, NRAS
29accommodative spasm10.5TG, TPO, TSHR
30ovarian cyst10.5CALCA, NKX2-1, TG
31organ system benign neoplasm10.5HRAS, NRAS, RET
32clivus chordoma10.5CALCA, NKX2-1, TSHR
33artemis deficiency10.5TG, TPO, TSHR
34bone cancer10.5CALCA, TG, TPO
35organ system cancer10.5CALCA, NKX2-1, PTEN
36clivus chondroid chordoma10.5HRAS, PTEN
37tenosynovitis of foot and ankle10.5HRAS, NRAS, PTEN
38deafness, autosomal recessive 4, with enlarged vestibular aqueduct10.5PAX8, TG, TPO
39benign struma ovarii10.5HRAS, LGALS3, RET, TG
40ovarian endometrioid cystadenoma10.5CALCA, TG, TPO
41perivascular epithelioid cell tumor10.4NKX2-1, RET, TG, TSHR
42hypertelorism, preauricular sinus, punctal pits, and deafness10.4TG, THRB, TPO, TSHR
43lingual goiter10.4CALCA, TG, TPO, TSHR
44substernal goiter10.4CALCA, TG, TPO, TSHR
45thyroid cancer, childhood10.4NKX2-1, PAX8, RET, TG
46renal hypertension10.4CALCA, TG, TPO, TSHR
47eccrine papillary adenocarcinoma10.4HRAS, NRAS
48frontal convexity meningioma10.4TG, THRB, TPO, TSHR
49medullary thyroid carcinoma, familial10.4CALCA, NKX2-1, RET, TG
50posterior uveitis10.4PAX8, TSHR

Graphical network of the top 20 diseases related to Thyroid Cancer, Nonmedullary, 2:



Diseases related to thyroid cancer, nonmedullary, 2

Symptoms for Thyroid Cancer, Nonmedullary, 2

About this section

Symptoms by clinical synopsis from OMIM:

188470

Clinical features from OMIM:

188470

HPO human phenotypes related to Thyroid Cancer, Nonmedullary, 2:

id Description Frequency HPO Source Accession
1 follicular thyroid carcinoma HP:0006731
2 abnormality of metabolism/homeostasis HP:0001939

Drugs & Therapeutics for Thyroid Cancer, Nonmedullary, 2

About this section

Drugs for Thyroid Cancer, Nonmedullary, 2 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 206)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
HydroxocobalaminapprovedPhase 422713422-51-011953898, 5460373, 44475014
Synonyms:
13422-51-0
22465-48-1
78091-12-0
8017-22-9
Acti-B12
AlphaRedisol
AlphaRedisol (TN)
Axion
Axlon
Benzimidazolyl ribofuranosyl phosphate deriv.
C08230
C62H85CoN13O15P
CHEBI:27786
CHEMBL1200742
CHEMBL235822
CID11622291
CID11953898
CID5460373
CID6433575
CID6474319
Ciplamin H
Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-Cobeta-hydroxocobamide
Cobalex
Cobalin H
Cobinamide dihydroxide dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole inner salt
Cobinamide, Co-hydroxy-, dihydrogen phosphate (ester), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, Co-hydroxy-, f-(dihydrogen phosphate), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono (inner salt), 3'- ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Cobinamide, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Codroxomin
Cyanokit
Cyanokit (TN)
D01027
DB00200
Depogamma
Docclan
Docelan
Docelvita
Docevita
Droxomin
Ducobee Hy
Ducobee-Hy
Duradoce
Duralta-12
EINECS 236-533-2
HSDB 3342
HYDROXOCOBALAMIN
Hidroxocobalamina
Hidroxocobalamina [INN-Spanish]
 
Hydro Cobex
Hydrobamine
Hydrocobalamin
Hydrogrisevit
Hydrovit
Hydroxocobalamin
Hydroxocobalamin (JAN/USP/INN)
Hydroxocobalamin Vitamin B12
Hydroxocobalamin [USAN:INN:BAN:JAN]
Hydroxocobalamin acetate
Hydroxocobalamin monohydrochloride
Hydroxocobalamin(alkaline soln.), OH- replaces CN- in Cyanocobalamin)
Hydroxocobalaminacetat
Hydroxocobalamine
Hydroxocobalamine [INN-French]
Hydroxocobalaminum
Hydroxocobalaminum [INN-Latin]
Hydroxocobemine
Hydroxomin
Hydroxy Cobal
Hydroxy vitamin B12
Hydroxycob(lll)alamin
Hydroxycobalamin
Hydroxycobalamine
Hyxobamine
Idrogrisevit
Idrossocobalamina
Idrossocobalamina [DCIT]
LS-54607
Lyovit-H
Neo-Betalin 12
Neo-cytamen
Neo-macrabin
Neo-rojamin
OH-Cbl
OH-Duphar
Ohb12
Oxobemin
Oxolamine (arcum)
Primabalt RP
Redisol-H
S1668_Selleck
Sytobex-H
UNII-Q40X8H422O
Vibeden
Vitadurin
Vitamin B(sub 12a)
Vitamin B-12b
Vitamin B12a
Vitamin B12b
a-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
alpha Cobione
alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
vitamin B-12b
2
Folic Acidapproved, nutraceuticalPhase 4, Phase 2292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
3
Cyanocobalaminapproved, nutraceuticalPhase 422768-19-944176380
Synonyms:
Anacobin
Bedoz
Berocca PN
Berubigen
Betalin 12
Betalin 12 Crystalline
Betaline-12
Betolvex
Bevidox
Bevidox concentrate
Biocobalamine
Byladoce
Cabadon m
Cernevit-12
Cobadoce forte
Cobalin
Cobavite
Cobex
Cobolin-M
Copharvit 5000
Covit
Crystamin
Crystamine
Crysti-12
Crystimin
Crystwel
Cyano-B12
Cyanobalamin concentrate
Cyanocob(III)alamin
Cyanocobalamin
Cyanocobalamin (JP15/USP)
Cyanocobalamin Co 57 Schilling Test Kit
Cyanocobalamine
Cyanocobalmin
Cyanoject
Cycobemin
Cycolamin
Cykobemin
Cykobeminet
Cyomin
Cyredin
Cytacon
Cytamen
Cytobion
Depinar
Dicopac
Dicopac Kit
Dimethylbenzimidazoylcobamide
Distivit
Docemine
Docibin
Docivit
Dodecabee
Dodecavite
Dodex
Duodecibin
Embiol
Emociclina
Eritrone
 
Erycytol
Erythrotin
Euhaemon
Extrinsic factor
Factor II
Fermin
Fresmin
Hemomin
Hepagon
Hepavis
Hepcovite
Hylugel plus
Infuvite Pediatric
Lactobacillus lactis dorner factor
M.V.I. Pediatric
Macrabin
Megabion
Megalovel
Milbedoce
Millevit
Nagravon
Nascobal
Nascobal (TN)
Neuroforte-R
Normocytin
Novidroxin
Pernaemon
Pernaevit
Pernipuron
Plecyamin
Poyamin
Primabalt
Rebramin
Redamina
Redisol
Rhodacryst
Rubesol
Rubivite
Rubramin
Rubramin PC
Rubratope-57 Kit
Rubratope-60 Kit
Rubripca
Rubrocitol
Ruvite
Shovite
Sytobex
Vi-Twel
Vibal
Vibalt
Vibisone
Virubra
Vita-rubra
Vitabee 12
Vitamin B12
Vitamin B12 Preparation
Vitamin B12 complex
Vitaped
Vitarubin
Vitral
vitamine b12
4Vitamin B ComplexPhase 4, Phase 22847
5Trace ElementsPhase 4, Phase 3, Phase 2, Phase 13900
6Vitamin B 12Phase 4227
7HormonesPhase 4, Phase 3, Phase 2, Phase 1, Phase 011748
8
IodinePhase 4, Phase 3, Phase 2, Phase 14947553-56-2807
Synonyms:
I2
Iode
Iodine-molecule
 
Iodio
Iodum
Jod
Jood
Tincture iodine
9MicronutrientsPhase 4, Phase 3, Phase 2, Phase 13901
10cadexomer iodinePhase 4, Phase 3, Phase 2, Phase 1456
11VitaminsPhase 4, Phase 3, Phase 23857
12HematinicsPhase 41121
13Insulin, Globin ZincPhase 44278
14insulinPhase 44278
15
ManganesePhase 4327439-96-527854
Synonyms:
 
Manganese
16Folinic AcidNutraceuticalPhase 4, Phase 22604
17FolateNutraceuticalPhase 4, Phase 22924
18
CobalaminNutraceuticalPhase 422713408-78-16438156
Synonyms:
5,6-Dimethyl-1-a-D-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-a-D-ribofuranosylbenzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosylbenzimidazole
Cob(III)alamin
Cobalamin (III)
Cobalamine
 
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
Hydroxomin
Rubivite
Rubratope-57
Rubratope-60
Ruvite
Vitamin B12
19
MethylcobalaminNutraceuticalPhase 422613422-55-4
Synonyms:
Algobaz
Co-Methylcobalamin
Hitocobamin M
MeCbl
Mecobalamin
Methycobal
 
Methyl cobalamine
Methyl vitamin B12
Methyl-5,6-dimethylbenzimidazolylcobalamin
Methyl-B12
Methylcob(III)alamin
Methylcobalamin
Methylcobaz
20Vitamin B9NutraceuticalPhase 4, Phase 22924
21InositolNutraceuticalPhase 469
22Vitamin B12NutraceuticalPhase 4227
23
Fentanylapproved, illicit, investigationalPhase 3705437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Abstral
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl - Novaplus
Fentanyl Citrate
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
 
Fentanyl-12
Fentanyl-25
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Lazanda
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
Subsys
UNII-UF599785JZ
fentanyl
24
ProgesteroneapprovedPhase 3, Phase 050057-83-05994
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17a-Progesterone
17alpha-Progesterone
17alpha-progesterone
17α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
46665_FLUKA
46665_RIEDEL
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC-700
AC1L1LKF
AI3-51682
Agolutin
Akrolutin
BB_NC-0185
BHR-100
BIDD:ER0547
BIDD:PXR0094
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
Bio-luton
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
CPD000058345
Colprosterone
Corlutin
Corlutina
Corluvite
Corporin
Corpus Luteum Hormone
Corpus luteum hormone
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
D00066
D4-Pregnene-3,20-dione
DB00396
DR-2011
Delalutin
Delta(4)-pregnene-3,20-dione
Duraprogen
EINECS 200-350-6
ETI-411
EU-0100895
Endometrin
Estima
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
HSDB 3389
Hormoflaveine
Hormoluton
Hydroxyprogesterone Caproate
Hydroxyprogesterone Caproic acid
LMST02030159
LS-234
Lingusorbs
Lipo-Lutin
Lipolutin
Lopac0_000895
Lucorteum
Lucorteum Sol
Lucorteum sol
Lugesteron
Luteal hormone
Luteinique
Luteocrin normale
Luteodyn
Luteogan
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin M
Lutocyclin
Lutocyclin M
 
Lutocyclin m
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MPA
Membrettes
Methylpregnone
Micronized Progesterone
MolPort-001-794-643
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
NCI60_042166
NSC 64377
NSC 9704
NSC-9704
NSC64377
NSC9704
Nalutron
Natural Progesterone
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
PROGESTERONE
Percutacrine
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Prestwick_411
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, water-soluble
Progesterone-Water Soluble
Progesterone: HBC complex
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Progestérone
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
SR-01000000088
SR-01000000088-5
Spectrum5_002053
Syngesterone
Syngestrets
Synovex S
Syntolutan
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
beta-Progesterone
bmse000482
component of Cyclogesterin
corpus luteum hormone
delta(4)-Pregnene-3,20-dione
delta(Sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta4-Pregnene-3,20-dione
luteohormone
nchembio.2007.53-comp14
25
rituximabapprovedPhase 3, Phase 11582174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
26
Sorafenibapproved, investigationalPhase 3, Phase 2671284461-73-0216239, 406563
Synonyms:
284461-73-0
4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide
4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate
4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE
AB1004622
AC-1674
AC1L50CF
BAX
BAY 43-9006
BAY 43-9006 (free base)
BAY 43-9006 tosylate salt
BAY 439006
BAY 54-9085 (tosylate salt)
BAY-43-0006
BAY-43-9006
BAY-54-9085
BAY43-9006
BRD-K23984367-001-01-8
Bio-0100
CHEBI:47228
CHEBI:50924
CHEMBL1336
CID216239
 
D08524
DB00398
DB07438
EN002709
I06-0856
K00597a
Kinome_766
LS-186067
LS-187021
LS-187788
MolPort-003-850-270
N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea
N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
NCGC00167488-01
NSC-724772
NSC747971
Nexavar
STK627350
Sorafenib
Sorafenib (INN)
Sorafenib Tosylate
Sorafenib [INN]
Sorafenib tosylate
Sorafenibum
UNII-9ZOQ3TZI87
ZINC01493878
nchembio.117-comp17
sorafenib
sorafenibum
27
Cholecalciferolapproved, nutraceuticalPhase 3, Phase 279967-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
 
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
calciol
cholecalciferol
delta-D
vitamin d-3
28Iodine-131 anti-B1 antibodyPhase 3, Phase 252
29Immunologic FactorsPhase 3, Phase 2, Phase 118483
30ImmunoglobulinsPhase 3, Phase 2, Phase 14477
31Antirheumatic AgentsPhase 3, Phase 2, Phase 18496
32Anti-Infective Agents, LocalPhase 3, Phase 2, Phase 1984
33Bone Density Conservation AgentsPhase 3, Phase 22600
34Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 2, Phase 09988
35Hormone AntagonistsPhase 3, Phase 2, Phase 010002
36Protein Kinase InhibitorsPhase 3, Phase 2, Phase 13162
37vitamin dPhase 3, Phase 21524
38ProgestinsPhase 3, Phase 0433
39Anesthetics, IntravenousPhase 31943
40Central Nervous System DepressantsPhase 3, Phase 210016
41AnalgesicsPhase 3, Phase 29358
42Anti-Infective AgentsPhase 3, Phase 2, Phase 117220
43Analgesics, OpioidPhase 32304
44AnestheticsPhase 37385
45Liver ExtractsPhase 3, Phase 2, Phase 13572
46Anesthetics, GeneralPhase 32274
47Peripheral Nervous System AgentsPhase 3, Phase 218510
48Antibodies, MonoclonalPhase 3, Phase 2, Phase 12413
49pancreatic polypeptidePhase 3, Phase 120
50AntibodiesPhase 3, Phase 2, Phase 14477

Interventional clinical trials:

(show top 50)    (show all 100)
idNameStatusNCT IDPhase
1Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound ParametersCompletedNCT01514942Phase 4
2Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.CompletedNCT00001730Phase 4
3A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.CompletedNCT00295763Phase 3
4Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 3
5Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins LymphomaCompletedNCT00268983Phase 3
6IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer PatientsRecruitingNCT01398085Phase 2, Phase 3
7Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast CancerRecruitingNCT01608451Phase 3
8Iodine I 131 With or Without Thyroid-Stimulating Hormone in Treating Patients Who Have Undergone Surgery for Thyroid CancerActive, not recruitingNCT00415233Phase 3
9Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid CancerActive, not recruitingNCT00984282Phase 3
10Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131CompletedNCT00085293Phase 2
11Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine TherapyCompletedNCT00104871Phase 2
12Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid CancerCompletedNCT00537095Phase 2
13Sutent Adjunctive Treatment of Differentiated Thyroid CancerCompletedNCT00668811Phase 2
14Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid CancerCompletedNCT00519896Phase 2
15Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid CancerCompletedNCT00134043Phase 2
16Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine TherapyCompletedNCT00729157Phase 2
17Thalidomide in Treating Patients With Thyroid CancerCompletedNCT00026533Phase 2
18Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid CancerCompletedNCT00251316Phase 2
19Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive IodineCompletedNCT00098813Phase 2
20Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid CancerCompletedNCT00118248Phase 2
21Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid CancerCompletedNCT00061906Phase 2
22Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid CancerCompletedNCT01164176Phase 2
23A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid CancerCompletedNCT00121628Phase 2
24Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsCompletedNCT00002608Phase 2
25Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNCT00019331Phase 2
26Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerCompletedNCT00365287Phase 1, Phase 2
27A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...CompletedNCT00923481Phase 2
28A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell OriginCompletedNCT01182285Phase 2
29Study Of AG-013736 In Patients With 131I-Refractory Thyroid CancerCompletedNCT00389441Phase 2
30Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell TransplantCompletedNCT00321932Phase 2
31Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 TositumomabCompletedNCT00933335Phase 2
32Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid CarcinomaCompletedNCT00887107Phase 2
33Phase I/II Study of IMMU-132 in Patients With Epithelial CancersRecruitingNCT01631552Phase 1, Phase 2
34Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid CancerRecruitingNCT02393690Phase 2
35Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid CancerRecruitingNCT02152995Phase 2
36Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid CancerRecruitingNCT01723202Phase 2
37Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid CancerRecruitingNCT01118065Phase 2
38External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesRecruitingNCT00637637Phase 2
39Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid CancerRecruitingNCT00786552Phase 2
40A Multicenter Phase II Pilot Open LabelRecruitingNCT01830504Phase 2
41Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical StudyRecruitingNCT02084732Phase 2
42Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid CancerRecruitingNCT01882816Phase 2
43REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid CarcinomasActive, not recruitingNCT00287287Phase 2
44Cediranib Maleate With or Without Lenalidomide in Treating Patients With Thyroid CancerActive, not recruitingNCT01208051Phase 1, Phase 2
45Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryActive, not recruitingNCT00381641Phase 2
46Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid CancerActive, not recruitingNCT00098852Phase 2
47Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine TherapyActive, not recruitingNCT00095836Phase 2
48Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantActive, not recruitingNCT00078858Phase 1, Phase 2
49Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerActive, not recruitingNCT00006251Phase 1, Phase 2
50Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid CancerActive, not recruitingNCT01025453Phase 2

Search NIH Clinical Center for Thyroid Cancer, Nonmedullary, 2


Cochrane evidence based reviews: adenocarcinoma, follicular

Genetic Tests for Thyroid Cancer, Nonmedullary, 2

About this section

Genetic tests related to Thyroid Cancer, Nonmedullary, 2:

id Genetic test Affiliating Genes
1 Thyroid Carcinoma, Follicular Somatic22 PTEN, NRAS

Anatomical Context for Thyroid Cancer, Nonmedullary, 2

About this section

MalaCards organs/tissues related to Thyroid Cancer, Nonmedullary, 2:

33
Thyroid, Lymph node, Lung, Bone, Kidney, Breast, Liver

Animal Models for Thyroid Cancer, Nonmedullary, 2 or affiliated genes

About this section

MGI Mouse Phenotypes related to Thyroid Cancer, Nonmedullary, 2:

38 (show all 22)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053719.9NRAS, PAX8, PTEN, RET, THRB, TPO
2MP:00053889.8HRAS, KDR, LGALS3, NKX2-1, PTEN, RET
3MP:00053679.7DIO2, HRAS, LGALS3, PAX8, PPARG, PTEN
4MP:00030129.7HRAS, KDR, NKX2-1, NRAS, PAX8, PPARG
5MP:00107719.6EGF, HRAS, KDR, LGALS3, NME1, NRAS
6MP:00053919.6EGF, KDR, NRAS, PPARG, PTEN, THRB
7MP:00020069.6HRAS, LGALS3, NKX2-1, NME1, NRAS, PPARG
8MP:00028739.5EGF, HRAS, KDR, MINPP1, NKX2-1, NRAS
9MP:00053819.5DIO2, EGF, LGALS3, NKX2-1, NRAS, PTEN
10MP:00053899.5EGF, LGALS3, NKX2-1, PAX8, PPARG, PTEN
11MP:00053869.4HRAS, KDR, LGALS3, NKX2-1, NRAS, PPARG
12MP:00053979.0KDR, LGALS3, NRAS, PPARG, PTEN, RET
13MP:00053859.0HRAS, KDR, LGALS3, NKX2-1, NRAS, PAX8
14MP:00036318.9HRAS, KDR, LGALS3, NKX2-1, NME1, PAX8
15MP:00053878.7EGF, KDR, LGALS3, NRAS, PPARG, PTEN
16MP:00053798.7DIO2, EGF, HRAS, NKX2-1, NME1, NRAS
17MP:00053908.7DIO2, HRAS, KDR, LGALS3, NKX2-1, PAX8
18MP:00107688.4HRAS, KDR, LGALS3, NKX2-1, NME1, NRAS
19MP:00053768.3DIO2, HRAS, KDR, LGALS3, NKX2-1, NRAS
20MP:00053788.3DIO2, EGF, HRAS, KDR, NKX2-1, NME1

Publications for Thyroid Cancer, Nonmedullary, 2

About this section

Variations for Thyroid Cancer, Nonmedullary, 2

About this section

Clinvar genetic disease variations for Thyroid Cancer, Nonmedullary, 2:

5
id Gene Variation Type Significance SNP ID Assembly Location
1SRGAP1NM_020762.2(SRGAP1): c.447A> C (p.Gln149His)single nucleotide variantPathogenicrs781626187GRCh38Chr 12, 64016970: 64016970
2SRGAP1NM_020762.2(SRGAP1): c.823G> A (p.Ala275Thr)single nucleotide variantPathogenicrs797044990GRCh37Chr 12, 64456718: 64456718
3SRGAP1NM_020762.2(SRGAP1): c.1849C> T (p.Arg617Cys)single nucleotide variantrisk factorrs114817817GRCh37Chr 12, 64502747: 64502747
4MINPP1NM_004897.4(MINPP1): c.122C> T (p.Ser41Leu)single nucleotide variantPathogenicrs119486096GRCh37Chr 10, 89264794: 89264794
5MINPP1NM_004897.4(MINPP1): c.809A> G (p.Gln270Arg)single nucleotide variantPathogenicrs104894171GRCh37Chr 10, 89268264: 89268264

Cosmic variations for Thyroid Cancer, Nonmedullary, 2:

7 (show top 50)    (show all 36261)
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Conf
1COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
2COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
3COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
4COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
5COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
6COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
7COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
8COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
9COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
10COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
11COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
12COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
13COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
14COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
15COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
16COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
17COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
18COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
19COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
20COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
21COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
22COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
23COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
24COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
25COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
26COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
27COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
28COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
29COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
30COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
31COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
32COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
33COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
34COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
35COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
36COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
37COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
38COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
39COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
40COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
41COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
42COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
43COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
44COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
45COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
46COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
47COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
48COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
49COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3
50COSM476BRAFthyroid,NS,carcinoma,papillary carcinoma3

Expression for genes affiliated with Thyroid Cancer, Nonmedullary, 2

About this section
Search GEO for disease gene expression data for Thyroid Cancer, Nonmedullary, 2.

Pathways for genes affiliated with Thyroid Cancer, Nonmedullary, 2

About this section

Pathways related to Thyroid Cancer, Nonmedullary, 2 according to GeneCards Suite gene sharing:

(show all 26)
idSuper pathwaysScoreTop Affiliating Genes
110.2HRAS, NRAS
2
Show member pathways
10.1KDR, VEGFC
3
Show member pathways
10.0EGF, HRAS, NRAS
410.0EGF, HRAS, NRAS
510.0HRAS, NKX2-1, PAX8
610.0TG, TPO, TSHR
79.9HRAS, NRAS, PTEN, RET
8
Show member pathways
9.9HRAS, NRAS, PPARG, TSHR
99.9EGF, KDR, PAX8
109.9DIO2, HRAS, NRAS, THRB
11
Show member pathways
9.9DIO2, HRAS, NRAS, THRB
129.9EGF, HRAS, NRAS, PTEN
13
Show member pathways
9.9EGF, HRAS, NRAS, PTEN
14
Show member pathways
9.9EGF, HRAS, NRAS, PTEN
15
Show member pathways
9.9EGF, HRAS, NRAS, PTEN
169.8EGF, HRAS, KDR, NRAS
179.8EGF, HRAS, KDR, RET
189.7HRAS, NRAS, PAX8, PPARG, RET
19
Show member pathways
9.7HRAS, KDR, NRAS, PTEN, VEGFC
20
Show member pathways
9.6NKX2-1, PAX8, TG, TPO, TSHR
21
Show member pathways
9.6NKX2-1, PAX8, TG, TPO, TSHR
22
Show member pathways
9.6EGF, HRAS, KDR, NRAS, VEGFC
239.5EGF, HRAS, KDR, NRAS, PTEN, VEGFC
24
Show member pathways
9.5EGF, HRAS, KDR, NRAS, PTEN, VEGFC
25
Show member pathways
9.5EGF, HRAS, KDR, NRAS, PTEN, VEGFC
269.2EGF, HRAS, NRAS, PAX8, PPARG, PTEN

GO Terms for genes affiliated with Thyroid Cancer, Nonmedullary, 2

About this section

Biological processes related to Thyroid Cancer, Nonmedullary, 2 according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1thyroid gland developmentGO:003087810.6NKX2-1, TG
2hormone biosynthetic processGO:004244610.5TG, TPO
3ERBB2 signaling pathwayGO:003812810.5EGF, HRAS, NRAS
4fibroblast growth factor receptor signaling pathwayGO:000854310.3EGF, HRAS, NRAS, PTEN
5organ morphogenesisGO:000988710.2HRAS, NKX2-1, THRB, VEGFC
6MAPK cascadeGO:000016510.2EGF, HRAS, NRAS, RET
7blood coagulationGO:000759610.1EGF, HRAS, NRAS, VEGFC
8vascular endothelial growth factor receptor signaling pathwayGO:004801010.1EGF, HRAS, NRAS, VEGFC
9thyroid hormone generationGO:00065909.9DIO2, TG, TPO
10activation of adenylate cyclase activityGO:00071909.9CALCA, TSHR
11neurotrophin TRK receptor signaling pathwayGO:00480119.8EGF, HRAS, NRAS, PTEN
12innate immune responseGO:00450879.5CALCA, EGF, HRAS, LGALS3, NRAS, PTEN

Sources for Thyroid Cancer, Nonmedullary, 2

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet